These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
290 related items for PubMed ID: 21497631
1. Cytomegalovirus infection and responsiveness to influenza vaccination in elderly residents of long-term care facilities. den Elzen WP, Vossen AC, Cools HJ, Westendorp RG, Kroes AC, Gussekloo J. Vaccine; 2011 Jun 24; 29(29-30):4869-74. PubMed ID: 21497631 [Abstract] [Full Text] [Related]
2. Benefits of increasing the dose of influenza vaccine in residents of long-term care facilities: a randomized placebo-controlled trial. Cools HJ, Gussekloo J, Remmerswaal JE, Remarque EJ, Kroes AC. J Med Virol; 2009 May 24; 81(5):908-14. PubMed ID: 19319953 [Abstract] [Full Text] [Related]
3. A nasally administered trivalent inactivated influenza vaccine is well tolerated, stimulates both mucosal and systemic immunity, and potentially protects against influenza illness. Langley JM, Aoki F, Ward BJ, McGeer A, Angel JB, Stiver G, Gorfinkel I, Shu D, White L, Lasko B, Dzongowski P, Papp K, Alexander M, Boivin G, Fries L. Vaccine; 2011 Feb 24; 29(10):1921-8. PubMed ID: 21219987 [Abstract] [Full Text] [Related]
4. Immunization with trivalent inactivated influenza vaccine in partially immunized toddlers. Englund JA, Walter EB, Gbadebo A, Monto AS, Zhu Y, Neuzil KM. Pediatrics; 2006 Sep 24; 118(3):e579-85. PubMed ID: 16950949 [Abstract] [Full Text] [Related]
5. Influenza vaccine immunogenicity in 6- to 23-month-old children: are identical antigens necessary for priming? Walter EB, Neuzil KM, Zhu Y, Fairchok MP, Gagliano ME, Monto AS, Englund JA. Pediatrics; 2006 Sep 24; 118(3):e570-8. PubMed ID: 16950948 [Abstract] [Full Text] [Related]
6. Mucosal (SIgA) and serum (IgG) immunologic responses in young adults following intranasal administration of one or two doses of inactivated, trivalent anti-influenza vaccine. Greenbaum E, Engelhard D, Levy R, Schlezinger M, Morag A, Zakay-Rones Z. Vaccine; 2004 Jun 30; 22(20):2566-77. PubMed ID: 15193382 [Abstract] [Full Text] [Related]
7. Safety and immunogenicity of trivalent inactivated influenza vaccine in infants: a randomized double-blind placebo-controlled study. Englund JA, Walter E, Black S, Blatter M, Nyberg J, Ruben FL, Decker MD, GRC28 Study Team. Pediatr Infect Dis J; 2010 Feb 30; 29(2):105-10. PubMed ID: 19934787 [Abstract] [Full Text] [Related]
8. Negative Effect of Age, but Not of Latent Cytomegalovirus Infection on the Antibody Response to a Novel Influenza Vaccine Strain in Healthy Adults. van den Berg SPH, Wong A, Hendriks M, Jacobi RHJ, van Baarle D, van Beek J. Front Immunol; 2018 Feb 30; 9():82. PubMed ID: 29434600 [Abstract] [Full Text] [Related]
9. Immune response to influenza vaccination in community-dwelling Chinese elderly persons. Hui SL, Chu LW, Peiris JS, Chan KH, Chu D, Tsui W. Vaccine; 2006 Jun 19; 24(25):5371-80. PubMed ID: 16713661 [Abstract] [Full Text] [Related]
10. [Comparative study on safety and immunogenicity between influenza subunit vaccine and split vaccine]. Dong PM, Li YQ, Zheng TZ, Jia YP, Li F, Han TW, Qiao RX, Zhang BH. Zhonghua Liu Xing Bing Xue Za Zhi; 2003 Jul 19; 24(7):570-3. PubMed ID: 12975010 [Abstract] [Full Text] [Related]
11. Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant. Goji NA, Nolan C, Hill H, Wolff M, Noah DL, Williams TB, Rowe T, Treanor JJ. J Infect Dis; 2008 Sep 01; 198(5):635-41. PubMed ID: 18694338 [Abstract] [Full Text] [Related]
12. Intradermal influenza vaccine for older adults: a randomized controlled multicenter phase III study. Arnou R, Icardi G, De Decker M, Ambrozaitis A, Kazek MP, Weber F, Van Damme P. Vaccine; 2009 Dec 09; 27(52):7304-12. PubMed ID: 19849996 [Abstract] [Full Text] [Related]
13. Intradermal influenza vaccine administered using a new microinjection system produces superior immunogenicity in elderly adults: a randomized controlled trial. Holland D, Booy R, De Looze F, Eizenberg P, McDonald J, Karrasch J, McKeirnan M, Salem H, Mills G, Reid J, Weber F, Saville M. J Infect Dis; 2008 Sep 01; 198(5):650-8. PubMed ID: 18652550 [Abstract] [Full Text] [Related]
14. Safety and immunogenicity profile of the concomitant administration of ZOSTAVAX and inactivated influenza vaccine in adults aged 50 and older. Kerzner B, Murray AV, Cheng E, Ifle R, Harvey PR, Tomlinson M, Barben JL, Rarrick K, Stek JE, Chung MO, Schödel FP, Wang WW, Xu J, Chan IS, Silber JL, Schlienger K. J Am Geriatr Soc; 2007 Oct 01; 55(10):1499-507. PubMed ID: 17908055 [Abstract] [Full Text] [Related]
15. Serum and mucosal immunologic responses in children following the administration of a new inactivated intranasal anti-influenza vaccine. Greenbaum E, Furst A, Kiderman A, Stewart B, Levy R, Schlesinger M, Morag A, Zakay-Rones Z. J Med Virol; 2001 Sep 01; 65(1):178-84. PubMed ID: 11505461 [Abstract] [Full Text] [Related]
16. Influenza A (H1N1) 2009 two-dose immunization of US children: an observer-blinded, randomized, placebo-controlled trial. Plennevaux E, Blatter M, Cornish MJ, Go K, Kirby D, Wali M, Reeves-Hoché MK, Denis M. Vaccine; 2011 Feb 11; 29(8):1569-75. PubMed ID: 21219979 [Abstract] [Full Text] [Related]
17. Detection of cytomegalovirus infection during a vaccine clinical trial in healthy young women: seroconversion and viral shedding. Zhang C, Buchanan H, Andrews W, Evans A, Pass RF. J Clin Virol; 2006 Mar 11; 35(3):338-42. PubMed ID: 16388984 [Abstract] [Full Text] [Related]
18. Influenza vaccine-mediated protection in older adults: Impact of influenza infection, cytomegalovirus serostatus and vaccine dosage. Merani S, Kuchel GA, Kleppinger A, McElhaney JE. Exp Gerontol; 2018 Jul 01; 107():116-125. PubMed ID: 28958701 [Abstract] [Full Text] [Related]
19. Prevaccination antibody titers can estimate the immune response to influenza vaccine in a rural community-dwelling elderly population. Matsushita M, Takeuchi S, Kumagai N, Uehara Y, Matsushita C, Arise K, Seo H, Awatani T. Vaccine; 2012 Feb 01; 30(6):1101-7. PubMed ID: 22178518 [Abstract] [Full Text] [Related]
20. Immunogenicity of a standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Scharpé J, Peetermans WE, Vanwalleghem J, Maes B, Bammens B, Claes K, Osterhaus AD, Vanrenterghem Y, Evenepoel P. Am J Kidney Dis; 2009 Jul 01; 54(1):77-85. PubMed ID: 19339089 [Abstract] [Full Text] [Related] Page: [Next] [New Search]